- Home
- ZNTL vs CDLX Comparison
ZNTL vs CDLX Comparison
Compare ZNTL & CDLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- CDLX
- Stock Information
- Founded
- ZNTL 2014
- CDLX 2008
- Country
- ZNTL United States
- CDLX United States
- Employees
- ZNTL N/A
- CDLX N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- CDLX Computer Software: Programming Data Processing
- Sector
- ZNTL Health Care
- CDLX Technology
- Exchange
- ZNTL Nasdaq
- CDLX Nasdaq
- Market Cap
- ZNTL 105.8M
- CDLX 98.2M
- IPO Year
- ZNTL 2020
- CDLX 2018
- Fundamental
- Price
- ZNTL $1.33
- CDLX $1.78
- Analyst Decision
- ZNTL Buy
- CDLX Hold
- Analyst Count
- ZNTL 7
- CDLX 5
- Target Price
- ZNTL $8.60
- CDLX $3.50
- AVG Volume (30 Days)
- ZNTL 1.4M
- CDLX 1.2M
- Earning Date
- ZNTL 08-08-2025
- CDLX 08-06-2025
- Dividend Yield
- ZNTL N/A
- CDLX N/A
- EPS Growth
- ZNTL N/A
- CDLX N/A
- EPS
- ZNTL N/A
- CDLX N/A
- Revenue
- ZNTL $26,865,000.00
- CDLX $272,588,000.00
- Revenue This Year
- ZNTL N/A
- CDLX N/A
- Revenue Next Year
- ZNTL N/A
- CDLX $5.51
- P/E Ratio
- ZNTL N/A
- CDLX N/A
- Revenue Growth
- ZNTL N/A
- CDLX N/A
- 52 Week Low
- ZNTL $1.01
- CDLX $1.22
- 52 Week High
- ZNTL $5.44
- CDLX $9.48
- Technical
- Relative Strength Index (RSI)
- ZNTL 50.91
- CDLX 50.89
- Support Level
- ZNTL $1.15
- CDLX $1.71
- Resistance Level
- ZNTL $1.38
- CDLX $1.91
- Average True Range (ATR)
- ZNTL 0.10
- CDLX 0.16
- MACD
- ZNTL 0.01
- CDLX 0.01
- Stochastic Oscillator
- ZNTL 75.00
- CDLX 50.54
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About CDLX Cardlytics Inc.
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K. and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.